Perkenalan

Halaman ini memberikan analisis komprehensif tentang riwayat insider trading yang diketahui di James B Weissman. Insider adalah pejabat, direktur, atau investor penting dalam suatu perusahaan. Adalah ilegal bagi insider untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik dan non-publik. Hal ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan ke SEC melalui Formulir 4. Meskipun ada pembatasan ini, penelitian akademis menunjukkan bahwa insider – secara umum – cenderung mengungguli pasar di perusahaan mereka sendiri.

Profitabilitas Perdagangan Rata-rata

Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari seluruh pembelian pasar terbuka yang dilakukan oleh insider dalam 3 tahun terakhir. Untuk menghitungnya, kami memeriksa setiap pembelian pasar terbuka dan tidak terencana yang dilakukan oleh insider, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata perdagangan tersebut selama 3, 6, dan 12 bulan, merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami menghitung rata-rata semua metrik kinerja untuk menghitung metrik kinerja bagi insider. Daftar ini hanya mencakup insider yang telah melakukan setidaknya tiga perdagangan dalam 2 tahun terakhir.

Jika profitabilitas perdagangan insider ini adalah "T/A", maka insider tersebut belum melakukan pembelian di pasar terbuka dalam 3 tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang dapat diandalkan.

Frekuensi Pembaruan: Harian

Lihat daftar insider trader yang paling menguntungkan.

Perusahaan dengan Posisi Insider yang Dilaporkan

Pengajuan SEC menunjukkan James B Weissman telah melaporkan kepemilikan atau perdagangan di perusahaan berikut:

Keamanan Judul Kepemilikan Terbaru yang Dilaporkan
Director 8.390
US:DRNA / Dicerna Pharmaceuticals Inc Chief Operating Officer & EVP 0
Bagaimana Menafsirkan Grafik

Bagan berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka dan tidak terencana yang dilakukan oleh James B Weissman. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham dipetakan sebagai persentase perubahan kumulatif harga saham. Misalnya, jika perdagangan insider dilakukan pada tanggal 1 Januari 2019, grafik akan menunjukkan persentase perubahan harian sekuritas hingga hari ini. Jika harga saham naik dari $10 menjadi $15 selama waktu ini, persentase perubahan harga saham kumulatif akan menjadi 50%. Perubahan harga dari $10 menjadi $20 adalah 100%, dan perubahan harga dari $10 menjadi $5 adalah -50%.

Pada akhirnya, kami mencoba untuk menentukan seberapa dekat korelasi perdagangan insider dengan keuntungan berlebih (positif atau negatif) pada harga saham untuk melihat apakah insider mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi insider. Pertimbangkan situasi di mana insider melakukan hal ini. Dalam situasi ini, kita mengharapkan (a) keuntungan positif setelah pembelian, atau (b) keuntungan negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, yang menunjukkan keuntungan positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, yang menunjukkan keuntungan negatif setelah setiap transaksi penjualan.

Namun, hal ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam kenaikan non-siklus selama bertahun-tahun, maka kita perkirakan semua lahan pasca pembelian akan miring ke atas. Demikian pula, penurunan non-siklus selama bertahun-tahun akan mengakibatkan penurunan pasca-perdagangan. Tak satu pun dari grafik ini menunjukkan aktivitas insider trading.

Indikator terkuat adalah situasi di mana harga saham sangat bersiklus, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat memberi isyarat kepada insider yang mengatur waktu perdagangan demi keuntungan finansial mereka.

Riwayat Insider Trading

Tabel ini menunjukkan daftar lengkap perdagangan insider yang dilakukan oleh James B Weissman sebagaimana diungkapkan kepada Securities Exchange Commission (SEC).

Tanggal Berkas Tanggal Trans Formulir Kode Keamanan Kode 10b5-1 Saham Sisa Saham Persen
Mengubah
Saham
Harga
Trans
Nilai
Tersisa
Nilai
2024-07-26 2024-07-24 4 TBIO Telesis Bio Inc.
Common Stock
A - Award 8.390 8.390
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -68.100 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -121.300 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -75.000 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -111.800 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -180.000 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -105.000 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -33.999 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -11.879 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Restricted Stock Units
D - Sale to Issuer -11.325 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Restricted Stock Units
D - Sale to Issuer -25.950 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
U - Other -18.100 0 -100,00 38,25 -692.325
2021-12-17 2021-12-15 4 DRNA Dicerna Pharmaceuticals Inc
Restricted Stock Units
M - Exercise -3.775 11.325 -25,00
2021-12-17 2021-12-15 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
F - Taxes -1.675 18.100 -8,47 38,05 -63.734 688.705
2021-12-17 2021-12-15 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 3.775 19.775 23,59
2021-07-08 2021-07-06 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -30.000 33.999 -46,88
2021-07-08 2021-07-06 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -30.000 16.000 -65,22 39,09 -1.172.700 625.440
2021-07-08 2021-07-06 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 30.000 46.000 187,50 9,09 272.700 418.140
2021-04-20 2021-04-16 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -4.904 16.000 -23,46 29,99 -147.071 479.840
2021-02-08 2021-02-05 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -7.156 20.904 -25,50 26,99 -193.140 564.199
2021-01-13 2021-01-12 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -5.808 28.060 -17,15 24,08 -139.868 675.741
2021-01-12 2021-01-12 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
A - Award 68.100 68.100
2021-01-12 2021-01-12 4 DRNA Dicerna Pharmaceuticals Inc
Restricted Stock Units
A - Award 15.100 15.100
2021-01-12 2021-01-11 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -3.800 33.868 -10,09 23,99 -91.162 812.493
2021-01-12 2021-01-08 4 DRNA Dicerna Pharmaceuticals Inc
Restricted Stock Units
M - Exercise -8.650 25.950 -25,00
2021-01-12 2021-01-08 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
F - Taxes -2.842 37.668 -7,02 23,29 -66.190 877.288
2021-01-12 2021-01-08 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 8.650 40.510 27,15
2020-12-03 2020-12-01 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4.360 0 -100,00
2020-12-03 2020-12-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -4.360 31.860 -12,04 25,21 -109.903 803.098
2020-12-03 2020-12-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4.360 36.220 13,68 3,42 14.911 123.872
2020-11-03 2020-11-02 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4.360 4.360 -50,00
2020-11-03 2020-11-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -4.360 31.860 -12,04 20,95 -91.333 667.403
2020-11-03 2020-11-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4.360 36.220 13,68 3,42 14.911 123.872
2020-10-22 2020-10-20 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -10.000 11.879 -45,71
2020-10-22 2020-10-20 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 10.000 31.860 45,75 2,97 29.700 94.624
2020-10-19 2020-10-15 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -8.720 8.720 -50,00
2020-10-19 2020-10-15 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -8.720 21.860 -28,52 20,20 -176.144 441.572
2020-10-19 2020-10-15 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 8.720 30.580 39,89 3,42 29.822 104.584
2020-09-04 2020-07-01 4/A DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4.360 25.980 -14,37
2020-09-04 2020-07-01 4/A DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -1.307 21.860 -5,64 26,87 -35.116 587.330
2020-09-04 2020-07-01 4/A DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -3.053 23.167 -11,64 26,39 -80.563 611.333
2020-09-04 2020-07-01 4/A DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4.360 26.220 19,95 2,97 12.949 77.873
2020-08-05 2020-08-03 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -259 17.440 -1,46
2020-08-05 2020-08-03 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4.101 21.879 -15,79
2020-08-05 2020-08-03 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -1.432 21.860 -6,15 22,80 -32.649 498.393
2020-08-05 2020-08-03 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -2.928 23.292 -11,17 22,31 -65.330 519.691
2020-08-05 2020-08-03 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 259 26.220 1,00 3,42 886 89.672
2020-08-05 2020-08-03 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4.101 25.961 18,76 2,97 12.180 77.104
2020-07-06 2020-07-01 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4.360 25.980 -14,37
2020-07-06 2020-07-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -1.307 21.860 -5,64 26,87 -35.116 587.330
2020-07-06 2020-07-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -3.053 23.167 -11,64 26,39 -80.563 611.333
2020-07-06 2020-07-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4.360 26.220 19,95 2,97 12.949 77.873
2020-06-02 2020-06-01 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4.360 30.340 -12,56
2020-06-02 2020-06-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -4.360 21.860 -16,63 21,06 -91.807 460.299
2020-06-02 2020-06-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4.360 26.220 19,95 2,97 12.949 77.873
2020-05-06 2020-05-04 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise 4.360 34.700 14,37
2020-05-06 2020-05-04 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -4.360 21.860 -16,63 20,20 -88.072 441.572
2020-05-06 2020-05-04 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4.360 26.220 19,95 2,97 12.949 77.873
2020-04-14 2020-04-13 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4.360 39.060 -10,04
2020-04-14 2020-04-13 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -4.360 21.860 -16,63 20,20 -88.072 441.572
2020-04-14 2020-04-13 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4.360 26.220 19,95 2,97 12.949 77.873
2020-03-03 2020-03-02 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4.360 43.420 -9,13
2020-03-03 2020-03-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -4.360 21.860 -16,63 20,61 -89.854 450.506
2020-03-03 2020-03-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4.360 26.220 19,95 2,97 12.949 77.873
2020-02-04 2020-02-03 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4.360 47.780 -8,36
2020-02-04 2020-02-03 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -4.360 21.860 -16,63 20,20 -88.072 441.572
2020-02-04 2020-02-03 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4.360 26.220 19,95 2,97 12.949 77.873
2020-01-10 2020-01-08 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
A - Award 121.300 121.300
2020-01-10 2020-01-08 4 DRNA Dicerna Pharmaceuticals Inc
Restricted Stock Units
A - Award 34.600 34.600
2020-01-03 2020-01-02 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -2.860 52.140 -5,20
2020-01-03 2020-01-02 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -1.500 0 -100,00
2020-01-03 2020-01-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -4.360 21.860 -16,63 21,88 -95.376 478.194
2020-01-03 2020-01-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 2.860 26.220 12,24 2,97 8.494 77.873
2020-01-03 2020-01-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 1.500 23.360 6,86 3,42 5.130 79.891
2019-12-19 2019-12-18 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -11.001 63.999 -14,67
2019-12-19 2019-12-18 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
F - Taxes -3.845 21.860 -14,96 26,01 -100.008 568.579
2019-12-19 2019-12-18 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 11.001 25.705 74,82 9,09 99.999 233.658
2019-12-03 2019-12-02 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -20.000 55.000 -26,67
2019-12-03 2019-12-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -20.000 14.704 -57,63 26,00 -520.000 382.304
2019-12-03 2019-12-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 20.000 34.704 136,02 2,97 59.400 103.071
2019-11-20 2019-11-19 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -20.000 0 -100,00
2019-11-20 2019-11-19 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -20.000 14.704 -57,63 24,00 -480.000 352.896
2019-11-20 2019-11-19 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 20.000 34.704 136,02 3,42 68.400 118.688
2019-11-20 2019-11-18 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -20.000 20.000 -50,00
2019-11-20 2019-11-18 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -20.000 14.704 -57,63 22,00 -440.000 323.488
2019-11-20 2019-11-18 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 20.000 34.704 136,02 3,42 68.400 118.688
2019-11-15 2019-11-14 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -20.000 40.000 -33,33
2019-11-15 2019-11-14 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -20.000 14.704 -57,63 20,00 -400.000 294.080
2019-11-15 2019-11-14 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 20.000 34.704 136,02 3,42 68.400 118.688
2019-11-01 2019-10-31 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -15.000 17.699 -45,87
2019-11-01 2019-10-31 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -15.000 14.704 -50,50 18,00 -270.000 264.672
2019-11-01 2019-10-31 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 15.000 29.704 102,01 3,42 51.300 101.588
2019-10-18 2019-10-18 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4.104 60.000 -6,40
2019-10-18 2019-10-18 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -800 0 -100,00
2019-10-18 2019-10-18 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4.104 14.704 38,72 3,42 14.036 50.288
2019-10-18 2019-10-18 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 800 10.600 8,16 3,42 2.736 36.252
2019-08-23 2019-08-23 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -14.680 9.800 -59,97 13,07 -191.832 128.062
2019-04-04 2019-04-02 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -15.000 32.699 -31,45
2019-04-04 2019-04-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -15.000 24.480 -37,99 15,00 -225.000 367.200
2019-04-04 2019-04-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 15.000 39.480 61,27 3,42 51.300 135.022
2019-01-04 2019-01-02 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
A - Award 180.000 180.000
2018-09-06 2018-09-05 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -2.301 47.699 -4,60
2018-09-06 2018-09-05 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -2.301 24.480 -8,59 17,50 -40.268 428.400
2018-09-06 2018-09-05 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 2.301 26.781 9,40 3,42 7.869 91.591
2018-08-20 2018-08-17 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -14.680 64.104 -18,63
2018-08-20 2018-08-17 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 14.680 24.480 149,80 3,42 50.206 83.722
2018-05-11 2018-05-09 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -10.000 50.000 -16,67
2018-05-11 2018-05-09 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -10.000 9.800 -50,51 15,00 -150.000 147.000
2018-05-11 2018-05-09 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 10.000 19.800 102,04 3,42 34.200 67.716
2018-04-24 2018-04-20 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -8.965 9.800 -47,78 13,00 -116.545 127.400
2018-03-21 2018-03-19 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -1.035 18.765 -5,23 13,00 -13.455 243.945
2018-01-08 2018-01-04 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
A - Award 105.000 105.000
2017-01-05 2017-01-03 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
A - Award 75.000 75.000
2016-05-16 2016-05-12 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
P - Purchase 4.170 19.800 26,68 3,29 13.719 65.140
2016-05-16 2016-05-12 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
P - Purchase 530 15.630 3,51 3,29 1.744 51.418
2016-05-16 2016-05-12 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
P - Purchase 300 15.100 2,03 3,24 972 48.922
2016-01-12 2016-01-08 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
A - Award 75.000 75.000
2015-01-13 2015-01-09 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
A - Award 75.000 75.000
2014-04-18 2014-04-16 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (right to buy)
A - Award 111.800 111.800
2014-02-20 2014-01-29 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
P - Purchase 1.000 13.116 8,25 15,00 15.000 196.740
2014-02-20 2014-01-27 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (right to buy)
M - Exercise -67 800 -7,73
2014-02-20 2014-01-27 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (right to buy)
M - Exercise -11.216 78.784 -12,46
2014-02-20 2014-01-27 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 11.283 12.116 1.354,50 3,24 36.557 39.256
2014-02-20 2013-11-11 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (right to buy)
M - Exercise -100 1.500 -6,25
2014-02-20 2013-11-11 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (right to buy)
M - Exercise -733 867 -45,81
2014-02-20 2013-11-05 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 833 833 3,42 2.849 2.849
2014-02-20 2013-09-24 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (right to buy)
A - Award 90.000 90.000
2014-02-20 2013-09-24 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (right to buy)
A - Award 60.000 60.000
2014-01-29 3 DRNA Dicerna Pharmaceuticals Inc
Common Stock
12.116
P
Pasar terbuka atau pembelian swasta atas sekuritas non-derivatif atau derivatif
S
Pasar terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi derivatif
D
Penjualan atau pengalihan surat berharga kembali kepada perusahaan
F
Pembayaran harga pelaksanaan atau kewajiban perpajakan dengan menggunakan sebagian surat berharga yang diterima dari perusahaan
G
Pemberian surat berharga oleh atau kepada insider
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Penggunaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Suatu transaksi dilaporkan secara sukarela pada Formulir 4
J
Lainnya (disertai catatan kaki yang menjelaskan transaksi)